“Lactobacillus brevis CD2 lozenge”的概念、定义、翻译、参考文献-科学参考

A lozenge containing an extract from the Lactobacillus brevis (L. brevis) with potential anti-inflammatory activity. As L. brevis CD2 contains high levels of arginine deiminase, which catalyzes the conversion of arginine to citrulline and ammonia, administration of this lozenge leads to hydrolysis of arginine in the oral cavity. The growth of bacteria, which depends on arginine, is halted, polyamine biosynthesis is reduced and the production of nitric oxide (NO) is reduced. The reduction in NO generation may further prevent inflammation in the oral cavity. Therefore, this agent may be able to reduce chemo- and radiotherapy-induced mucositis.

单词	Lactobacillus brevis CD2 lozenge
释义	Lactobacillus brevis CD2 lozenge A lozenge containing an extract from the Lactobacillus brevis (L. brevis) with potential anti-inflammatory activity. As L. brevis CD2 contains high levels of arginine deiminase, which catalyzes the conversion of arginine to citrulline and ammonia, administration of this lozenge leads to hydrolysis of arginine in the oral cavity. The growth of bacteria, which depends on arginine, is halted, polyamine biosynthesis is reduced and the production of nitric oxide (NO) is reduced. The reduction in NO generation may further prevent inflammation in the oral cavity. Therefore, this agent may be able to reduce chemo- and radiotherapy-induced mucositis.
随便看	vector Vector Quantity Vector Quantity Vectrin vecuronium bromide vedolizumab vegan vegetative reproduction VEGF VEGF-AS VEGF/HGF-targeting DARPin MP0250 VEGF inhibitor PTC299 VEGFR1-1084 peptide vaccine VEGFR2-169 peptide vaccine VEGFR-2 DNA vaccine VXM01 VEGFR-2 inhibitor CT-322 VEGFR2-targeted contrast agent BR55 VEGFR2 tyrosine kinase inhibitor PF-00337210 VEGFR/FGFR inhibitor ODM-203 VEGFR inhibitor KRN951 VEGFR/PDGFR dual kinase inhibitor TAK-593 VEGFR/PDGFR dual kinase inhibitor X-82 VEGFR tyrosine kinase inhibitor VEGF Trap Veglin